| Drug Name |
Natrecor |
| Drug ID |
BADD_D01540 |
| Description |
Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). Nesiritide is a 32 amino acid recombinant human B-type natriuretic peptide. |
| Indications and Usage |
For the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity. |
| Marketing Status |
approved; investigational |
| ATC Code |
C01DX19 |
| DrugBank ID |
DB04899
|
| KEGG ID |
D05147
|
| MeSH ID |
D020097
|
| PubChem ID |
91976508
|
| TTD Drug ID |
D05GRY
|
| NDC Product Code |
35207-0009 |
| UNII |
P7WI8UL647
|
| Synonyms |
Natriuretic Peptide, Brain | Peptide, Brain Natriuretic | BNP-32 | BNP 32 | Brain Natriuretic Peptide-32 | Brain Natriuretic Peptide 32 | Natriuretic Peptide-32, Brain | Peptide-32, Brain Natriuretic | Natriuretic Factor-32 | Natriuretic Factor 32 | BNP Gene Product | Type-B Natriuretic Peptide | Natriuretic Peptide, Type-B | Type B Natriuretic Peptide | Natriuretic Peptide Type-B | Natriuretic Peptide Type B | Nesiritide | Brain Natriuretic Peptide | B-Type Natriuretic Peptide | Natriuretic Peptide, B-Type | Ventricular Natriuretic Peptide, B-type | Ventricular Natriuretic Peptide, B type | Natrecor |
